Linear immunoglobulin A bullous dermatosis associated with herpes simplex virus infection and Kawasaki disease.
Hayashi
Masahiro
M
Monma
Fumiko
F
Katagiri
Yoshiyuki
Y
Kawaguchi
Masakazu
M
Suzuki
Tamio
T
D000212:Acyclovir / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001485:Basement Membrane / Q000276:immunology / Q000473:pathology; D003622:Dapsone / Q000627:therapeutic use; D006023:Glycoproteins / Q000627:therapeutic use; D006561:Herpes Simplex / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D007070:Immunoglobulin A / Q000276:immunology*; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D011239:Prednisolone / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000821:virology
D006023:Glycoproteins; D007070:Immunoglobulin A; D003622:Dapsone; D011239:Prednisolone; C028665:urinastatin; D001241:Aspirin; D000212:Acyclovir